| Previous Close | 0.075 |
| Open | 0.000 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 13,907 |
| Market Cap | 4.08M |
| Beta | 2.29 |
| PE Ratio (TTM) | -4.69 |
| EPS (TTM) | -0.02 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.00 |
- GlobeNewswire•last month
Capstone Therapeutics Announces Transaction for Sale of Shares of Its Common Stock and Secured Loan
TEMPE, Ariz., July 17, 2017-- Capstone Therapeutics Corp. announced today that on July 14, 2017, BP Peptides, LLC purchased 13,500,000 newly issued shares of Capstone Common Stock, for $1,012,500 and provided ...
- Accesswire•2 years ago
Capstone Therapeutics, Inc. - "Following the Data"
NEW YORK, NY / ACCESSWIRE / April 27, 2015 / Capstone Therapeutics (OTCQB:CAPS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman and CEO, Jock Holliman, ...
We're sorry this is all we were able to find about this topic.
